Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 521 results for "ranbaxy laboratories"

Ranbaxy inks licensing pact with Canada's Cipher to sell acne drug in Brazil
Business Standard India

Ranbaxy and Cipher sign agreement

To sell and distribute Cipher's isotretinoin capsules in Brazil Ranbaxy Laboratories has signed a licensing agreement with Cipher Pharmaceuticals to exclusively market, sell and distribute Cipher's isotretinoin capsules in Brazil. The agreement ... Express Pharma, 14 hours ago
[x]  

269 images for ranbaxy laboratories

Financial Express, 1 day ago
Financial Express, 1 week ago
Bio Spectrum Asia, 1 week ago
India TV, 4 days ago
Financial Express, 4 weeks ago
4 Traders, 3 weeks ago
Orlando Sentinel, 4 weeks ago
4 Traders, 4 weeks ago
Value Walk, 4 weeks ago
Investing.com, 1 week ago

Ranbaxy gains after inking licensing pact with Cipher

Ranbaxy Laboratories rose 1.81% to Rs 571.45 at 11:22 IST on BSE after the company said it entered into a licencing agreement with Canada's Cipher Pharmaceuticals Inc to exclusively market the latter's isotretinoin capsules in Brazil. The ...
 Capital Market16 hours ago

Dr Reddy's, Glenmark, Ranbaxy to get astro support: Gupta

According to Satish Gupta of astrostocktips.in, pharma stocks like Dr Reddy's Laboratories, Glenmark Pharma, Shasun Pharmaceuticals and Ranbaxy Laboratories will be getting astrological support.
 Money Control17 hours ago Biocon, Bata, Dr Reddy's Labs to get astro support: Gupta  Money Control3 days ago
Pharma Letter

Sun Pharma pops buyout pill again

After a blockbuster deal to acquire Ranbaxy Laboratories, Sun Pharma today announced that it was buying US-based Pharmalucence Inc for an undisclosed amount. Pharmalucence, which has sterile injectable capacity in the US, has been acquired by one of the ...
 The Telegraph1 week ago Ranbaxy to market Cipher Pharma's isotretinoin capsules in Brazil  PharmaBiz1 day ago Sector Update: Healthcare; Valeant Files Official Complaint Against Allergan, Cipher Grants Ranbaxy Rights to Sell Isotretinoin in Brazil, ProMetic Unit Signs Agreement With Existing Multinational Client  Nasdaq1 day ago RANBAXY LABORATORIES : Glenmark joins pharma companies setting up US plants  4 Traders1 week ago
[x]  

Ranbaxy, Cipher join hands for Brazil venture

Ranbaxy Laboratories and Cipher Pharmaceuticals have entered into a licencing agreement under which Ranbaxy would market, sell and distribute the latter's isotretinoin capsules in Brazil. The agreement extends the current relationship with Cipher, ...
 Hindu Business Line1 day ago
Financial Express

Ranbaxy CEO sweetener a bitter pill for proxy firm

Even as beleaguered Indian drug maker Ranbaxy Laboratories struggles to avoid being categorised as a sick company under prevailing Indian laws, it has sought shareholder approval to raise the limit for chief executive Arun Sawhney's remunerations to ...
 Financial Express1 day ago
India TV

Ranbaxy-Sun Pharma deal gets nod from BSE, NSE

The two leading stock exchanges -- BSE and NSE -- have given clearance to $4-billion merger of Ranbaxy Laboratories with Sun Pharmaceutical Industries. The 'no-objection' from the two exchanges would allow both the entities to file their scheme of ...
 Indian-Commodity3 days ago Sun Pharma-Ranbaxy deal gets no-objection from BSE, NSE  Hindu Business Line4 days ago Sun Pharma-Ranbaxy Deal Gets 'No-Objection' From BSE, NSE  Silicon India3 days ago Sun Pharma-Ranbaxy deal gets nod from BSE, NSE  Indian-Commodity3 days ago
[x]  

Sun Pharma-Ranbaxy merger gets BSE, NSE approval

BSE and NSE have approved the merger of Ranbaxy Laboratories with Sun Pharmaceutical clearing a at regulatory hurdle facing consummation of the pharma deal. Report stated that the approval of the BSE and the NSE will allow Sun Pharma to delist ...
 EHealth Magazine3 days ago SUN PHARMA-RANBAXY &4-BILLION DEAL GETS BSE, NSE APPROVAL  TMC Net3 days ago

Pharmaceutical companies like Ranbaxy Laboratories, Sanofi India and others fume at price control order

MUMBAI: The drug price regulator's move to control the prices of more commonly used diabetes and heart disease medicines has made pharmaceutical companies furious, as they fear it would wipe out their margins just when they seemed to recover from ...
 Economic Times1 week ago Pharma cos fume at price control order  Economic Times1 week ago

Ranbaxy Laboratories gains on inking licensing agreement with Cipher Pharmaceuticals

Ranbaxy Laboratories is currently trading at Rs. 567.70 up by 6.40 points or 1.14% from its previous closing of Rs. 561.30 on the BSE. The scrip opened at Rs. 565.00 and has touched a high and low of Rs. 568.60 and Rs. 564.00 respectively. So far ...
 Arihant Capital18 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - ranbaxy laboratories
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less